PGNY Progyny

Progyny, Inc. Promotes Seasoned Executive Mark Livingston to Chief Financial Officer

Progyny, Inc. Promotes Seasoned Executive Mark Livingston to Chief Financial Officer

Livingston Will Continue Reporting to Pete Anevski, Progyny’s President and Chief Operating Officer

NEW YORK, Sept. 09, 2020 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, today announced that Mark Livingston, Progyny’s Executive Vice President of Finance, has been promoted to Chief Financial Officer, effective as of September 15, 2020. In this expanded role, Mr. Livingston will continue to report to Pete Anevski, Progyny’s President and Chief Operating Officer. Mr. Anevski had also been Progyny’s CFO since 2017.

Mr. Livingston, 54, joined Progyny in 2019, bringing more than 30 years of experience in accounting, public company reporting, and financial planning and analysis at leading healthcare, technology and media companies. He has previously served as CFO of the international business at Scripps Network Interactive and as CFO at Emerson, Reid & Company, an employee benefits wholesaler. Mr. Livingston has also held senior financial leadership roles at WebMD and Hess Corporation.

“I have known and worked with Mark for over 20 years. He is an exceptional leader who played a critical role both in ensuring Progyny’s readiness to become a public company as well as our continued success following the offering, and I look forward to continue working closely with him in this expanded role,” said Mr. Anevski. “Progyny is in the earliest stages of addressing its significant market opportunities. With Mark now leading our financial operations, I am able to increase my focus on scaling the business for continued growth and executing our long-term strategic vision.”

“When Mark joined Progyny, we looked to him to broaden and enhance the capabilities of our finance and accounting functions, and through his energy, expertise and insight, he has helped extend Progyny’s leadership position in the market,” said David Schlanger, Chief Executive Officer of Progyny. “We couldn’t be more pleased to see him take on a larger role at Progyny and to begin working with the investment community more closely.”

“Progyny is transforming fertility benefits management, providing a better experience and achieving optimal outcomes for patients, employers and physicians,” said Mr. Livingston. “This is an incredibly exciting time for the company, and I look forward to addressing our substantial market opportunities.”  

Mr. Livingston received his bachelor's degree in Management and Accounting from Tulane University and is a licensed Certified Public Accountant.

About Progyny

Progyny (Nasdaq: PGNY) is a leading fertility benefits management company in the US. We are redefining fertility and family building benefits, proving that a comprehensive and inclusive fertility solution can simultaneously benefit employers, patients, and physicians.  

Our benefits solution empowers patients with education and guidance from a dedicated Patient Care Advocate (PCA), provides access to a premier network of fertility specialists using the latest science and technologies, reduces healthcare costs for the nation’s leading employers, and drives optimal clinical outcomes. We envision a world where anyone who wants to have a child can do so. 

Headquartered in New York City, Progyny has been recognized for its leadership and growth by CNBC Disruptor 50, Modern Healthcare’s Best Places to Work in Healthcare, Financial Times, INC. 5000, and Crain’s Fast 50 for NYC. For more information, visit .

For Further Information, Please Contact:

Investors:

James Hart

Media:

Selena Yang

EN
09/09/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Progyny

 PRESS RELEASE

Progyny Adds Pelvic Floor Therapy, Continuing to Close Gaps in Care Ac...

Progyny Adds Pelvic Floor Therapy, Continuing to Close Gaps in Care Across Women’s Health With nearly one third of women impacted by pelvic floor disorders, expanded care access and education from Progyny will help eliminate the silent suffering NEW YORK, June 24, 2025 (GLOBE NEWSWIRE) -- , Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, today announced that it is adding to its comprehensive offering of women’s health and family building solutions. With the expansion of its network of specialty trained women’s health providers, and the addition of ...

 PRESS RELEASE

Progyny Joins Amazon’s Health Benefits Connector Program as First Wome...

Progyny Joins Amazon’s Health Benefits Connector Program as First Women’s Health and Family Building Solution The collaboration will enable Amazon customers who are eligible for Progyny services to discover and enroll in fertility, family building, and menopause benefits. NEW YORK, June 10, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, today announced a new collaboration with Amazon’s Health Benefits Connector to expand access to comprehensive women’s health services. Through Amazon’s Health Benefits Connector, el...

 PRESS RELEASE

Progyny Adds Distinguished Healthcare Executive Elizabeth Bierbower to...

Progyny Adds Distinguished Healthcare Executive Elizabeth Bierbower to Board of Directors NEW YORK, May 29, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, today announced the addition of healthcare veteran Elizabeth Bierbower to its Board of Directors. "As we continue to round out our board's experience, Elizabeth's extensive leadership with some of the largest health plans and deep financial expertise will be invaluable as we scale and innovate across the women's health and family building spectrum," said Pete Anev...

 PRESS RELEASE

Progyny Appoints Two Renowned Women’s Health Experts to Medical Adviso...

Progyny Appoints Two Renowned Women’s Health Experts to Medical Advisory Board Medical Advisory Board additions support company’s growing product offerings across women’s health and family building NEW YORK, May 14, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, today announced the appointment of Morehouse School of Medicine’s Regional Dean for Seattle and Puget Sound’s Dr. Gloria Richard-Davis – a double-board certified physician in Obstetrics and Gynecology and Reproductive Endocrinology and Infertility, a fell...

 PRESS RELEASE

Progyny, Inc. to Present at BofA Securities 2025 Health Care Conferenc...

Progyny, Inc. to Present at BofA Securities 2025 Health Care Conference NEW YORK, May 12, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, today announced that Progyny’s Chief Executive Officer, Pete Anevski, and Chief Financial Officer, Mark Livingston, will participate in a fireside chat at the BofA Securities 2025 Health Care Conference on Wednesday, May 14, 2025, at 3:00 P.M. Pacific Time / 6:00 P.M. Eastern Time. A live audiocast and replay will be available from the Events and Presentations section of Progyny’s ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch